107 results
Page 3 of 6
8-K
EX-99.1
fpcjtdej8cx8y89ui4
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
e5io4hhxpvklkye03t
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
ts6y7ppnhap3zbhuv 5z
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
8ihplr yyqebwc
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-99.2
disli2
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
19gl2qwyv5bnhmpt96jv
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-99.1
7efet 4r47r2v9j5
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
9rmqzxliih2x85e
28 Sep 21
Regulation FD Disclosure
7:30am
424B5
kjjw1awv98t w41znww
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-99.1
ej3o o5dqtnrr5j99i
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
0sb21rz3e 9u4kz7
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
1jpsug un3ogl183
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.1
2kii1
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
xcbjvt4yyhcp7dds
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
2vqnf i630jz0fur0d
1 Mar 21
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:03pm